Pralatrexate
Back to searchMolecule Structure
Scientific Name
Pralatrexate
Description of the Drug
Pralatrexate is an antineoplastic agent used for the treatment of relapsed or refractory peripheral T-cell lymphoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06813
http://www.drugbank.ca/drugs/DB06813
Brand Name(s)
Folotyn
Company Owner(s)
Acrotech Biopharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dihydrofolate reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL202 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL21633 | |
| DrugBank | DB06813 | |
| PubChem: Thomson Pharma | 14761163 | 14907808 |
| PubChem | 148121 | |
| LINCS | LSM-45944 | |
| Nikkaji | J557.257F | |
| BindingDB | 50457437 | |
| EPA CompTox Dashboard | DTXSID3048578 | |
| DrugCentral | 4117 | |
| Brenda | 77178 | 209749 |
| ChemicalBook | CB31856065 | |
| Guide to Pharmacology | 6840 | |
| rxnorm | FOLOTYN | PRALATREXATE |
| ChEBI | 71223 |
